The Role of Thioredoxin System in Cancer Immunotherapy
Author Information
Author(s): Sun Lin, Yu Anni, Yang Yang, Wang Zhiruo, Wang Wenqian, Luo Lan
Primary Institution: State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China.
Hypothesis
The thioredoxin system is crucial for tumor growth and immune response, and its expression levels correlate with tumor progression and immunotherapy responses.
Conclusion
The Trx system is a good predictor of both survival and the efficacy of immunotherapy, as well as clinical prognosis.
Supporting Evidence
- An abnormal expression of the Trx system is observed in cancer cells.
- Interference with the Trx system significantly inhibits tumor cell growth.
- The Trx system showed a relatively consistent aberrant expression in pan-cancer.
- The abnormal expression of the thioredoxin system was positively correlated with immune infiltration.
- The Trx system was associated with immune response to immunotherapy.
Takeaway
The thioredoxin system helps cancer cells grow and affects how well immunotherapy works, making it an important target for treatment.
Methodology
The study analyzed Trx system protein expression using various databases and methods, including Western blotting and survival analysis.
Limitations
Further investigation is necessary to determine the applicability of the Trx system as a prognostic model in clinical practice.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website